| ACHD | Adult Congenital Heart Disease |
| ASA | Acetylsalicylic Acid |
| AT1 blockers | Angiotensin II Receptor Type 1 Blockers |
| AHA | American Heart Association |
| ACC | American College of Cardiology |
| BMI | Body Mass Index |
| CHD | Congenital Heart Disease |
| EDC | Electronic Data Capture |
| ESC | European Society of Cardiology |
| FC | Functional Class (Perloff Classification) |
| GDPR | General Data Protection Regulation |
| GPP | Good Pharmacoepidemiology Practice |
| GPS | Good Practice in Secondary Data Analysis |
| HF | Heart Failure |
| MUC-HF-Class | Munich Heart Failure Classification for Congenital Heart Disease |
| NOACs | Non-Vitamin K Oral Anticoagulants |
| PATHFINDER-CHD | Patients with Heart Failure Due to Congenital Heart Disease (Registry) |
| SD | Standard Deviation |
| SGLT2 inhibitors | Sodium-Glucose Cotransporter 2 Inhibitors |